174 related articles for article (PubMed ID: 15010143)
21. Solid form selection of zwitterionic 5-HT4 receptor agonist.
Kojima T; Sugano K; Onoue S; Murase N; Sato M; Kawabata Y; Mano T
Int J Pharm; 2008 Feb; 350(1-2):35-42. PubMed ID: 17919860
[TBL] [Abstract][Full Text] [Related]
22. Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: Solid-state characterisation of a trihydrate form.
Bartolomei M; Rodomonte A; Antoniella E; Minelli G; Bertocchi P
J Pharm Biomed Anal; 2007 Nov; 45(3):443-9. PubMed ID: 17709225
[TBL] [Abstract][Full Text] [Related]
23. Water mediates the metastable crystal-to-stable crystal phase transition process in phospholipid aqueous dispersion.
Wu FG; Chen L; Yu ZW
J Phys Chem B; 2009 Jan; 113(4):869-72. PubMed ID: 19125632
[TBL] [Abstract][Full Text] [Related]
24. Physical characterization of pantoprazole sodium hydrates.
Zupancic V; Ograjsek N; Kotar-Jordan B; Vrecer F
Int J Pharm; 2005 Mar; 291(1-2):59-68. PubMed ID: 15707732
[TBL] [Abstract][Full Text] [Related]
25. Preparation and physicochemical properties of niclosamide anhydrate and two monohydrates.
van Tonder EC; Maleka TS; Liebenberg W; Song M; Wurster DE; de Villiers MM
Int J Pharm; 2004 Jan; 269(2):417-32. PubMed ID: 14706253
[TBL] [Abstract][Full Text] [Related]
26. The effect of temperature and moisture on the amorphous-to-crystalline transformation of stavudine.
Strydom S; Liebenberg W; Yu L; de Villiers M
Int J Pharm; 2009 Sep; 379(1):72-81. PubMed ID: 19540323
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure and physicochemical characterization of ambazone monohydrate, anhydrous, and acetate salt solvate.
Muresan-Pop M; Braga D; Pop MM; Borodi G; Kacso I; Maini L
J Pharm Sci; 2014 Nov; 103(11):3594-3601. PubMed ID: 25187325
[TBL] [Abstract][Full Text] [Related]
28. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
Zeitler JA; Kogermann K; Rantanen J; Rades T; Taday PF; Pepper M; Aaltonen J; Strachan CJ
Int J Pharm; 2007 Apr; 334(1-2):78-84. PubMed ID: 17129691
[TBL] [Abstract][Full Text] [Related]
29. Insights into hydrate formation and stability of morphinanes from a combination of experimental and computational approaches.
Braun DE; Gelbrich T; Kahlenberg V; Griesser UJ
Mol Pharm; 2014 Sep; 11(9):3145-63. PubMed ID: 25036525
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the physical and chemical stability of niclosamide crystal forms in aqueous versus nonaqueous suspensions.
de Villiers MM; Mahlatji MD; van Tonder EC; Malan SF; Lötter AP; Liebenberg W
Drug Dev Ind Pharm; 2004 Jul; 30(6):581-92. PubMed ID: 15285331
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical properties of tamoxifen hemicitrate sesquihydrate.
Kojima T; Katoh F; Matsuda Y; Teraoka R; Kitagawa S
Int J Pharm; 2008 Mar; 352(1-2):146-51. PubMed ID: 18061380
[TBL] [Abstract][Full Text] [Related]
32. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
33. One-solvent polymorph screen of carbamazepine.
Getsoian A; Lodaya RM; Blackburn AC
Int J Pharm; 2008 Feb; 348(1-2):3-9. PubMed ID: 17945448
[TBL] [Abstract][Full Text] [Related]
34. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
Timmermann IL; Steckel H; Trunk M
Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
[TBL] [Abstract][Full Text] [Related]
35. Kinetic study of the transformation of mefenamic acid polymorphs in various solvents and under high humidity conditions.
Kato F; Otsuka M; Matsuda Y
Int J Pharm; 2006 Sep; 321(1-2):18-26. PubMed ID: 16765543
[TBL] [Abstract][Full Text] [Related]
36. High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals.
Luu V; Jona J; Stanton MK; Peterson ML; Morrison HG; Nagapudi K; Tan H
Int J Pharm; 2013 Jan; 441(1-2):356-64. PubMed ID: 23178596
[TBL] [Abstract][Full Text] [Related]
37. The relative stability of xylazine hydrochloride polymorphous forms.
Bērziņs A; Krūkle K; Actiņs A; Kreismanis JP
Pharm Dev Technol; 2010; 15(2):217-22. PubMed ID: 19640258
[TBL] [Abstract][Full Text] [Related]
38. Solvent influences on metastable polymorph lifetimes: real-time interconversions using energy dispersive X-ray diffractometry.
DeMatos LL; Williams AC; Booth SW; Petts CR; Taylor DJ; Blagden N
J Pharm Sci; 2007 May; 96(5):1069-78. PubMed ID: 17455330
[TBL] [Abstract][Full Text] [Related]
39. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
Sun CC
Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure study and investigation of solid-state cyclization for AMG 222, a channel hydrate.
Kiang YH; Nagapudi K; Liu J; Staples RJ; Jona J
Int J Pharm; 2013 Jan; 441(1-2):299-306. PubMed ID: 23182974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
